E
ProPhase Labs, Inc. PRPH
$0.3396 -$0.0107-3.06% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -292.63% -28.13% -78.87% -1,239.09% -258.06%
Total Depreciation and Amortization -64.17% 31.62% 16.90% 30.43% 68.57%
Total Amortization of Deferred Charges 1,285.71% 1,067.92% 879.17% 630.00% --
Total Other Non-Cash Items 621.33% -34.91% -48.50% 35.15% -63.66%
Change in Net Operating Assets 306.12% 50.56% 78.52% 10.54% 423.07%
Cash from Operations -374.24% 13.41% 30.75% -1,175.42% -192.85%
Capital Expenditure 198.33% 73.65% 96.06% -81.62% 85.03%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 74.32% -100.00% -100.00% 161.35% 68.56%
Cash from Investing 96.84% -129.22% -89.79% 247.40% 74.74%
Total Debt Issued -- -- -- -67.63% --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -100.00% -- -- --
Repurchase of Common Stock -- -- -- -- 100.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 27.74% 138.00% 11,425.53% 35.18% 130.79%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -86.33% 59.29% 110.87% -181.94% 106.63%